The committee's advice was sought on one application, to extend the indications for the vaccine. The committee provided advice on a range of issues.
Further details of the ACV discussion and advice associated with this pre-market item will be released within the Australian Public Assessment Report (AusPAR). Please note that there is a delay between when an application is considered by the ACV and the publication of the AusPAR. To browse all AusPARs see AusPAR search.
Section B: Safety
No item was on the agenda seeking the committee's advice on safety or pharmacovigilance issues.
Section C: Immunisation Programs
No item was on the agenda seeking the committee's advice on the immunisation programs.
